Clover Health Investments Income Statement (2019-2026) | CLOV

Income Statement Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Revenue & cost
Revenue (Quarter)
195.36M203.66M432.04M278.17M268.50M267.89M281.99M317.09M314.38M301.23M287.61M341.72M356.26M330.99M310.71M462.33M469.83M496.65M455.13M744.19M
Cost of Revenue (Quarter)
458.50M436.32M441.93M861.72M858.79M839.80M-1567.23M274.79M244.26M235.78M249.75M265.16M248.35M249.77M243.04M353.44M377.99M423.47M413.50M589.65M
Gross Profit (Quarter)
-263.15M-232.67M-9.89M-583.55M-590.28M-571.91M1,849.22M42.30M70.12M65.44M37.86M76.56M107.91M81.21M67.67M108.89M91.83M73.18M41.63M154.54M
Operating items
Selling, General & Administrative (Quarter)
45.65M45.85M55.18M57.70M47.04M47.83M51.11M57.64M41.71M41.03M42.70M44.57M44.42M35.20M52.29M50.67M48.48M48.95M66.16M74.63M
Restructuring Costs (Quarter)
0.07M
Other Operating Expenses (Quarter)
548.69M530.57M563.65M904.16M902.39M883.08M-1510.16M344.05M307.31M298.61M332.81M325.06M304.65M304.57M306.12M412.93M439.69M472.07M470.87M647.23M
Operating Expenses (Quarter)
594.33M576.42M618.83M961.86M949.43M930.91M-1458.98M401.69M349.02M339.64M375.52M369.62M349.07M339.77M358.41M463.61M488.18M521.03M537.03M721.86M
Operating Income (Quarter)
-181.86M-149.25M-186.79M-87.48M-102.73M-74.10M-22.36M-79.70M-28.88M-33.62M-63.13M-22.70M7.19M-8.79M-21.45M-1.27M-10.56M-24.38M-49.32M27.33M
EBIT (Quarter)
-181.86M-149.25M-186.79M-87.48M-102.73M-74.10M-22.36M-79.70M-28.88M-33.62M-63.13M-22.70M7.19M-8.79M-21.45M-1.27M-10.56M-24.38M-49.32M27.33M
Non-operating items
Non Operating Investment Income (Quarter)
12.39M-1.23M-0.98M-0.97M-4.73M-0.47M
Interest & Investment Income (Quarter)
Other Non Operating Income (Quarter)
Net income details
EBT (Quarter)
-183.07M-149.66M-185.68M-135.08M-107.73M-74.50M-23.05M-587.20M-498.38M-38.12M-63.13M-25.48M4.87M-24.98M-21.45M-31.17M-25.76M-44.18M-49.61M26.43M
Profit After Tax (Quarter)
-317.61M-34.72M-188.53M-75.49M-104.36M-77.90M-84.23M-79.70M-28.81M-33.62M-70.47M-23.17M7.71M-9.15M-18.22M-1.27M-10.58M-24.38M-51.38M27.33M
Income from Non-Controlling Interests (Quarter)
0.07M-0.20M-1.32M-5.32M-1.09M-2.41M1.39M2.34M0.32M1.64M2.70M-0.19M0.30M3.11M-2.44M1.51M0.25M0.29M0.06M-1.20M
Income from Continuing Operations (Quarter)
-183.07M-149.66M-185.68M-135.08M-107.73M-74.50M-23.05M-587.20M-498.38M-38.12M-63.13M-25.48M4.87M-24.98M-21.45M-31.17M-25.76M-44.18M-49.61M26.43M
Consolidated Net Income (Quarter)
-183.07M-149.66M-185.68M-135.08M-107.73M-74.50M-23.05M7.09M0.07M-7.85M-2.51M4.00M0.24M-0.40M-0.57M26.43M
Income towards Parent Company (Quarter)
-183.07M-149.66M-185.68M-135.08M-107.73M-74.50M-23.05M7.09M0.07M-7.85M-2.51M4.00M0.24M-0.40M-0.57M26.43M
Net Income towards Common Stockholders (Quarter)
-183.07M-149.66M-185.68M-135.08M-107.73M-74.50M-23.05M7.09M0.07M-7.85M-2.51M4.00M0.24M-0.40M-0.57M26.43M
Additional items
EPS (Basic) (Quarter)
-0.45-0.36-0.45-0.29-0.23-0.16-0.050.010.00-0.02-0.010.010.000.000.000.05
EPS (Diluted) (Quarter)
-0.45-0.36-0.45-0.29-0.23-0.16-0.050.010.00-0.02-0.010.010.000.000.000.05
Shares Outstanding (Quarter)
408.16M414.57M412.92M473.03M476.06M477.69M476.24M478.81M479.16M480.77M482.18M567.45M487.48M490.18M490.02M497.06M509.04M512.74M511.97M522.18M
Shares Outstanding (Diluted) (Quarter)
408.16M414.57M412.92M473.03M476.06M477.69M476.24M478.81M479.16M480.77M482.18M486.37M495.18M490.18M490.02M497.06M509.04M512.74M511.97M532.50M
EBITDA (Quarter)
-181.86M-149.25M-186.79M-87.48M-102.73M-74.10M-22.36M-79.70M-28.88M-33.62M-63.13M-22.70M7.19M-8.79M-21.45M-1.27M-10.56M-24.38M-49.32M27.33M
Interest Expenses (Quarter)
1.21M0.40M-1.11M47.60M5.00M0.40M0.69M507.50M469.50M4.50M2.78M2.32M16.20M29.90M15.20M19.80M0.29M0.90M